Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report [PDF]
Surgical Case Reports, 2023 Background Atezolizumab plus bevacizumab therapy was recently introduced as the first line for unresectable advanced hepatocellular carcinoma (HCC), but immune-related adverse events (IrAEs) due to atezolizumab are a great concern.
Shintaro Arakaki +13 more
doaj +4 more sources
Massive Intramuscular Haematoma Due to Acquired Factor V Deficiency [PDF]
eJHaemLara Budwig +5 more
doaj +4 more sources
Congenital Factor V deficiency: perioperative management (case report) [PDF]
The Pan African Medical Journal, 2020 Factor V congenital deficiency is a rare hereditary disease, it exposes patients to hemorrhagic risk, with high morbi-mortality. Its management is a real challenge for practitioners.
Mohamed Anass Fehdi +5 more
doaj +2 more sources
Recurrent bleeding after posthemorrhoidectomy caused by factor V deficiency: a case report and review of the literature [PDF]
Annals of Coloproctology, 2022 Congenital factor V (FV) deficiency is a rare hemorrhagic disorder that can cause excessive bleeding during and after surgery in the affected patient. This report is the case of a patient who had FV deficiency with recurrent posthemorrhoidectomy bleeding
Jun Seong Chung +2 more
doaj +2 more sources
Challenges in management of unusual acquired factor V deficiency: A case report. [PDF]
Medicine (Baltimore), 2019 Rationale: Acquired inhibitors of coagulation are antibodies that either inhibit the activity or increase the clearance of a clotting factor. Acquired factor V deficiency is a rare coagulation disorder, and it can sometimes be life threatening.
Takemoto K +4 more
europepmc +2 more sources
Severe serous cavity bleeding caused by acquired factor V deficiency associated with lymphatic leakage in a hemodialysis patient: A case report. [PDF]
World J Clin Cases, 2019 BACKGROUND Acquired factor V deficiency is a rare secondary hemorrhagic disease, which can lead to a severe bleeding disorder. CASE SUMMARY We report a 47-year-old hemodialysis patient who presented with severe hemorrhagic pleural effusion and ...
Zhao WB +6 more
europepmc +2 more sources
A Case of Acquired Factor V Deficiency in a Hemodialysis Patient: A Case Report With Literature Review [PDF]
IJU Case ReportsIntroduction Acquired factor V (FV) deficiency is a rare bleeding disorder requiring careful management, especially in hemodialysis (HD) patients who regularly receive anticoagulants.
Akihiko Sugino +9 more
doaj +2 more sources
Seminars in Thrombosis and Hemostasis, 1983 Factor V is a plasma glycoprotein that is apparently synthesized in the liver parenchymal cells. It circulates in plasma as a single chain molecule with an approximate molecular weight of 300,000.
Eberhard Mammen
openaire +2 more sources
Factor V deficiency: a concise review [PDF]
Haemophilia, 2008 Summary. Factor V (FV; proaccelerin or labile factor) is the plasma cofactor for the prothrombinase complex that activates prothrombin to thrombin. FV deficiency can be caused by mutations in the FV gene or in genes encoding components of a putative cargo receptor that transports FV (and factor VIII) from the endoplasmic reticulum to the Golgi ...
J N, Huang, M A, Koerper
openaire +3 more sources
Factor V Deficiency in Korean Patients: Clinical and Laboratory Features, Treatment, and Outcome. [PDF]
J Korean Med Sci, 2016 Due to rarity of factor V (FV) deficiency, there have been only a few case reports in Korea. We retrospectively analysed the clinical-laboratory features of FV deficiency in 10 Korean patients.
Park YH, Lim JH, Yi HG, Lee MH, Kim CS.
europepmc +2 more sources